Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

C. Oliver Hanemann; Sylwia Ammoun; D. Gareth Evans; David A. Hilton; Adam Streeter; Christopher Hayward

doi:10.1136/jnnp-2018-319713

Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

C. Oliver Hanemann^*
, Sylwia Ammoun
, D. Gareth Evans
, David A. Hilton
, Adam Streeter
, Christopher Hayward

^*Corresponding author for this work

Peninsula Medical School

Imperial College Healthcare NHS Trust
University Hospitals Plymouth NHS Trust

Research output: Contribution to journal › Article › peer-review

25 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Journal of Neurology, Neurosurgery and Psychiatry
Volume	0
Issue number	0
Early online date	4 Feb 2019
DOIs	https://doi.org/10.1136/jnnp-2018-319713
Publication status	Published - 4 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/jnnp-2018-319713

Manuscript JNNP Ammoun et al revision notmarkedLicence: CC BY-NC-ND

Cite this

@article{2ef1ba41c79646439418bc092bb369b8,

title = "Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2",

author = "Hanemann, \{C. Oliver\} and Sylwia Ammoun and Evans, \{D. Gareth\} and Hilton, \{David A.\} and Adam Streeter and Christopher Hayward",

year = "2019",

month = feb,

day = "4",

doi = "10.1136/jnnp-2018-319713",

language = "English",

volume = "0",

journal = "Journal of Neurology, Neurosurgery and Psychiatry",

issn = "0022-3050",

publisher = "BMJ Publishing Group",

number = "0",

}

TY - JOUR

T1 - Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

AU - Hanemann, C. Oliver

AU - Ammoun, Sylwia

AU - Evans, D. Gareth

AU - Hilton, David A.

AU - Streeter, Adam

AU - Hayward, Christopher

PY - 2019/2/4

Y1 - 2019/2/4

UR - https://pearl.plymouth.ac.uk/pms-research/158/

U2 - 10.1136/jnnp-2018-319713

DO - 10.1136/jnnp-2018-319713

M3 - Article

SN - 0022-3050

VL - 0

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

IS - 0

ER -

Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

UN SDGs

Access to Document

Other files and links

Cite this